No connection

Search Results

DVA vs EHC

DVA
DaVita Inc.
NEUTRAL
Price
$151.85
Market Cap
$10.01B
Sector
Healthcare
AI Confidence
85%
EHC
Encompass Health Corporation
BULLISH
Price
$101.98
Market Cap
$10.14B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
DVA
15.97
EHC
18.37
Forward P/E
DVA
9.26
EHC
15.74
P/B Ratio
DVA
-15.99
EHC
4.18
P/S Ratio
DVA
0.73
EHC
1.71
EV/EBITDA
DVA
8.77
EHC
9.86

Profitability

Gross Margin
DVA
32.26%
EHC
43.21%
Operating Margin
DVA
15.23%
EHC
18.35%
Profit Margin
DVA
5.47%
EHC
9.54%
ROE
DVA
64.85%
EHC
24.82%
ROA
DVA
7.32%
EHC
9.66%

Growth

Revenue Growth
DVA
9.9%
EHC
9.9%
Earnings Growth
DVA
6.5%
EHC
21.2%

Financial Health

Debt/Equity
DVA
11.11
EHC
0.83
Current Ratio
DVA
1.29
EHC
1.08
Quick Ratio
DVA
1.17
EHC
0.83

Dividends

Dividend Yield
DVA
--
EHC
0.75%
Payout Ratio
DVA
0.0%
EHC
12.97%

AI Verdict

DVA NEUTRAL

DaVita Inc. presents a dichotomy between attractive valuation and precarious financial leverage, anchored by a stable but mediocre Piotroski F-Score of 4/9. While the stock trades at a compelling Forward P/E of 9.26 and a PEG ratio of 0.56, suggesting significant undervaluation relative to growth, this is offset by an extreme Debt/Equity ratio of 11.11 and negative book value. Bearish insider sentiment, characterized by a $199.94M sale, and a weak technical trend (10/100) further temper the bullish case. The stock is currently trading very close to its analyst target price and intrinsic value, leaving limited immediate upside.

Strengths
Highly attractive valuation with a Forward P/E of 9.26
Strong growth efficiency indicated by a PEG ratio of 0.56
Consistent historical track record of earnings beats over 25 quarters
Risks
Extreme financial leverage with a Debt/Equity ratio of 11.11
Negative Price/Book ratio (-15.99) indicating negative shareholder equity
Strongly bearish insider activity with significant recent selling
EHC BULLISH

EHC presents a stable financial profile with a Piotroski F-Score of 4/9 and a significant valuation gap between its defensive Graham Number ($55.18) and growth-based Intrinsic Value ($163.72). The company exhibits exceptional operational efficiency with an ROE of 24.82% and a highly attractive PEG ratio of 0.41, suggesting the stock is undervalued relative to its earnings growth. While insider sentiment is bearish and technical trends are currently weak, the long-term fundamental trajectory is supported by a 25-quarter track record of consistent earnings beats. The current price of $101.98 represents a reasonable entry point given the analyst target of $142.73.

Strengths
Exceptional earnings track record with consistent beats over 25 quarters
Very low PEG ratio (0.41) indicating strong growth at a reasonable price
High Return on Equity (24.82%) demonstrating efficient capital use
Risks
Bearish insider activity with significant selling by the CEO and other officers
Weak technical trend (0/100) indicating short-term price momentum is negative
Tight liquidity with a current ratio of 1.08

Compare Another Pair

DVA vs EHC: Head-to-Head Comparison

This page compares DaVita Inc. (DVA) and Encompass Health Corporation (EHC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile